SIOG – International Society of Geriatric Oncology shared a post on LinkedIn:
“New in JGO
Deprescribing in older adults with cancer and polypharmacy
Polypharmacy affects most older adults with cancer and increases the risk of adverse outcomes. But what makes deprescribing feasible in oncology care?
This qualitative study explores perspectives from patients and healthcare professionals, identifying barriers such as time constraints, care fragmentation, and uncertainty around roles.
Facilitators included team-based care, better communication, and pharmacist involvement, which was consistently highlighted across all groups.”
Title: Barriers and facilitators of deprescribing for older adults with cancer and polypharmacy
Authors: Kofi Gyasi Agyei, Arul Malhotra, Sally Norton, Mostafa Mohamed, Katherine Juba, Supriya Mohile, Erika Ramsdale
Read the Full Article on Journal of Geriatric Oncology
Other posts about SIOG on OncoDaily.